Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ABEO stock hub

Abeona Therapeutics Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ABEOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

335.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ABEO

In the news

Latest news · ABEO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/E5.8

P25 14.9P50 23.2P75 38.5

ROE70

P25 -105.6P50 -46.5P75 -3.1

ROIC-44.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ABEO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000318306
Company name	Abeona Therapeutics Inc.
Country	United States
Country code	US
Cusip	00289Y107
Employees	226
Employees Change	90%
Employees Change Percent	66.18
Enterprise value	$169.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	1980-09-19
Isin	US00289Y2063
Last refreshed	2026-05-10
Market cap	$335.6M
Market cap category	Small-Cap
Price	$5.9
Price currency	USD
Rev Per Employee	25,752.21x
Sector	Healthcare
Sic	2834
Symbol	ABEO
Website	https://www.abeonatherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	21.21%
EV Earnings	2.38x
EV Sales Forward	2.59x
EV/Sales	29.07x
FCF yield	-25.12%
P/B ratio	2.04x
P/E ratio	5.82x
P/S ratio	57.66x
PS Forward	5.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-24.4M
Net Income	$71.2M
Net Income Growth Years	1%
Pretax Margin	1,224.79%
Profit Margin	1,223.08%
Profit Per Employee	$314,969
Profitable Years	1
ROA	-34.04
Roa5y	-39.57
ROCE	-47.08
ROE	70.05
Roe5y	-127.8
ROIC	-44.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-20.74%
Cagr15y	-33.81%
Cagr1y	12.07%
Cagr20y	-24.49%
Cagr3y	21.61%
Cagr5y	-31.28%
EPS Growth Years	6
Revenue Growth Years	0x
Revenue Growth3 Y	60.26x
Revenue Growth5 Y	-10.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.04
Assets	$219.6M
Cash	$191.4M
Current Assets	$204.9M
Current Liabilities	$29.6M
Debt	$25M
Debt Equity	$0.16
Equity	$159.2M
Interest Coverage	-23.92
Liabilities	$60.4M
Long Term Assets	$14.7M
Long Term Liabilities	$30.8M
Net Cash	$166.4M
Net Cash By Market Cap	$49.59
Net Cash Growth	122.89%
Net Debt Equity	$-1.05
Tangible Book Value	$159.2M
Tangible Book Value Per Share	$2.89
WACC	11.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.93
Net Working Capital	$-3M
Quick ratio	6.7
Working Capital	$175.3M
Working Capital Turnover	$0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-61.12%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-90.21%
1Y total return	12.06%
200-day SMA	5.4
3Y total return	79.88%
50-day SMA	5.06
50-day SMA vs 200-day SMA	50under200
5Y total return	-84.68%
All Time High	343,750
All Time High Change	-100%
All Time High Date	1996-03-08
All Time Low	2.19
All Time Low Change	169.41%
All Time Low Date	2023-02-24
ATR	0.26
Beta	1.34
Beta1y	1.7
Beta2y	1.45
Ch YTD	11.95
High	5.96
High52	7.54
High52 Date	2025-08-15
High52ch	-21.75%
Low	5.74
Low52	4
Low52 Date	2025-11-07
Low52ch	47.5%
Ma50ch	16.72%
Premarket Change Percent	1.21
Premarket Price	$5.84
Premarket Volume	226
Price vs 200-day SMA	9.3%
RSI	63.52
RSI Monthly	47.47
RSI Weekly	59.91
Sharpe ratio	0.4x
Sortino ratio	0.74
Total Return	-61.12%
Tr YTD	11.95
Tr15y	-99.79%
Tr1m	22.66%
Tr1w	8.66%
Tr3m	15.01%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$20
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.38
Earnings Revenue Estimate	5,071,200x
Operating Income	$-89.4M
Operating margin	-1,536.9
Price target	$20
Price Target Change	$239
Price Target Change Top	$239

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,248,829%
Float Percent	69%
Shares Insiders	16.83%
Shares Institutions	55.09%
Shares Out	56,882,523
Shares Qo Q	1.8%
Shares Yo Y	61.12%
Short Float	41.96%
Short Ratio	11.22
Short Shares	28.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-95.1M
Average Volume	947,322.85x
Bv Per Share	2.89
CAPEX	$-8M
Ch10y	-90.21
Ch15y	-99.79
Ch1m	22.66
Ch1w	8.66
Ch1y	12.06
Ch20y	-99.64
Ch3m	15.01
Ch3y	79.88
Ch5y	-84.68
Ch6m	40.48
Change	2.25%
Change From Open	1.55
Close	5.77
Days Gap	0.69
Depreciation Amortization	2,549,000
Dollar Volume	5,037,697.3
Earnings Date	2026-05-13
Earnings Time	bmo
EBIT	$-89.4M
EBITDA	$-86.9M
EPS	$1.01
F Score	3
FCF	$-84.3M
FCF EV Yield	-49.83x
FCF Per Share	$-1.48
Financing CF	26,040,000
Fiscal Year End	December
Founded	1,974
Graham Number	8.12457
Graham Upside	37.7
Income Tax	$100,000
Investing CF	105,028,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-17
Last Report Date	2025-12-31
Last Split Date	2022-07-05
Last Split Type	Reverse
Last10k Filing Date	2026-03-17
Ma150	5.07
Ma150ch	16.35%
Ma20	5.52
Ma20ch	6.96%
Net CF	54,742,000
Next Earnings Date	2026-05-13
Open	5.81
Optionable	Yes
Position In Range	72.73
Post Close	5.9
Postmarket Change Percent	-1.02
Postmarket Price	$5.84
Ppne	13,883,000
Pre Close	5.77
Price Date	2026-05-08
Ptbv Ratio	2.11
Relative Volume	0.9x
Revenue	5,820,000x
SBC By Revenue	185.21x
Share Based Comp	10,779,000
Tax By Revenue	1.72x
Tax Rate	0.14%
Tr20y	-99.64%
Tr6m	40.48%
Us State	Ohio
Volume	853,847
Z Score	-2.31

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ABEO pay a dividend?

Capital-return profile for this ticker.

Performance

ABEO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ABEO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+55.1%

Float: +69.0% of shares outstanding

Insider ownership

+16.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ABEO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.5

Neutral momentum band

Price vs 200-day MA

+9.3%

50/200-day relationship not available

Beta (5Y)

1.34

More volatile than the market

Sharpe ratio

0.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ABEO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ABEO stock rating?

Abeona Therapeutics Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ABEO analysis?

The full report lives at /stocks/ABEO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ABEO?

The latest report frames ABEO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ABEO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.